Add Yahoo as a preferred source to see more of our stories on Google. Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One ...
This week, Hims & Hers’ (NYSE:HIMS) recent Super Bowl ad campaign was at least twice mentioned by Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA) as a glaring example of how ...
Novo Nordisk has sued Hims & Hers for patent infringement, saying the online site is selling cheaper, unapproved copies of the Wegovy weight loss drug ...
The ad, which aired during the Super Bowl over the weekend, promoted a new product by Hims & Hers, a blood test designed to detect over 50 types of cancer before symptoms appear. This includes hard-to ...
Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...
10don MSN
Hims & Hers’ expansion plans — as well as its Super Bowl ad — have investors worried about profits
The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Hims & Hers Health Inc. HIMS shares are down during Tuesday’s premarket session as the company reported mixed fourth-quarter earnings results. The stock’s decline follows a report that revealed ...
Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One company is taking them to the Super Bowl so that anyone can try them. Hims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results